Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

α-Synuclein in synaptic function and dysfunction
Manu Sharma, Jacqueline Burré
Trends in Neurosciences (2022) Vol. 46, Iss. 2, pp. 153-166
Open Access | Times Cited: 91
Multifunctional nanoparticles for image-guided drug delivery in nuclear medicine: advancements and applications
Bilal AbdulMajeed Mukhlif, Muhammad Ikram Ullah, Subasini Uthirapathy, et al.
Journal of Radioanalytical and Nuclear Chemistry (2025)
Closed Access | Times Cited: 1
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 37
Harnessing Graphdiyne for Selective Cu2+ Detection: A Promising Tool for Parkinson’s Disease Diagnostics and Pathogenesis
Jing Jiang, Xu Wang, Yongqi Bao, et al.
ACS Sensors (2024) Vol. 9, Iss. 5, pp. 2317-2324
Closed Access | Times Cited: 8
Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation
Bingkuan Xu, Jing Chen, Yinghui Liu
ACS Omega (2022) Vol. 7, Iss. 34, pp. 30281-30290
Open Access | Times Cited: 36
Myricetin Inhibits α‐Synuclein Amyloid Aggregation by Delaying the Liquid‐to‐Solid Phase Transition
Bingkuan Xu, Xiaoli Mo, Jing Chen, et al.
ChemBioChem (2022) Vol. 23, Iss. 16
Closed Access | Times Cited: 27
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Sandesh Neupane, Elena De Cecco, Adriano Aguzzi
Journal of Molecular Biology (2022) Vol. 435, Iss. 12, pp. 167930-167930
Open Access | Times Cited: 25
Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations
Jamoliddin Razzokov, Sunnatullo Fazliev, Mukhriddin Makhkamov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6312-6312
Open Access | Times Cited: 13
Recombinant Antibody Fragments for Immunotherapy of Parkinson’s Disease
Karen Manoutcharian, Goar Gevorkian
BioDrugs (2024) Vol. 38, Iss. 2, pp. 249-257
Open Access | Times Cited: 5
Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies
Rimpi Arora, Ashish Baldi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 19, pp. 1459-1471
Closed Access | Times Cited: 5
Refining the clinical diagnosis of Parkinson's disease
Eoin Mulroy, Roberto Erro, Kailash P. Bhatia, et al.
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106041-106041
Closed Access | Times Cited: 4
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
Diverse pathways for the treatment of Parkinson’s disease: Integration and development of traditional and emerging therapies
Yuanyuan Zuo, Xuying Ding, Zhenye Liu, et al.
Neuroscience (2025)
Closed Access
Impact of Peripheral Inflammation on Blood–Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases
Ana Isabel Beltrán-Velasco, Vicente Javier Clemente‐Suárez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2440-2440
Open Access
Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53
Jacques Fantini, Fodil Azzaz, Anaïs Aulas, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Real-life ankle submovements and computer mouse use reflect patient-reported function in adult ataxias
Nicole M. Eklund, Jessey S. Ouillon, Vineet Pandey, et al.
Brain Communications (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 10
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Alessandra Bigi, Roberta Cascella, Cristina Cecchi
Neural Regeneration Research (2023) Vol. 18, Iss. 11, pp. 2332-2342
Open Access | Times Cited: 8
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henrı́quez, Mahesh Narayan
Exploration of Neuroprotective Therapy (2023), pp. 207-234
Open Access | Times Cited: 8
Targeted protein degradation for the treatment of Parkinson’s disease: Advances and future perspective
Roshanak Amirian, Mehdi Azadi Badrbani, Hossein Derakhshankhah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115408-115408
Open Access | Times Cited: 8
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 2
From protein biomarkers to proteomics in dementia with Lewy Bodies
Augoustos Tsamourgelis, Peter G. Swann, Leonidas Chouliaras, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101771-101771
Open Access | Times Cited: 10
E46K Mutation of α-Synuclein Preorganizes the Intramolecular Interactions Crucial for Aggregation
Defa Huang, Cong Guo
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4803-4813
Closed Access | Times Cited: 5
Neurotrophic Factors in Parkinson’s Disease: Clinical Trials
Arun Kumar Mahato, Märt Saarma
Stem cell biology and regenerative medicine (2024), pp. 109-137
Closed Access | Times Cited: 1
Engineered Nanobodies With Programmable Target Antigen Proteolysis (Ptap) Fusions Regulate Intracellular Alpha-synuclein in Vitro and in Vivo
Jeffrey H. Kordower, David Butler, Diptaman Chatterjee, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Molecular docking analysis of α-Synuclein aggregation with Anle138b
Annu Grewal, Deepak Sheokand, Vandana Saini, et al.
Bioinformation (2024) Vol. 20, Iss. 3, pp. 217-222
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top